Home > Practice guidelines for the administration of buprenorphine for treating opioid use disorder.

Office of the Secretary, Department of Health and Human Services. (2021) Practice guidelines for the administration of buprenorphine for treating opioid use disorder. Washington DC: Department of Health and Human Services. 86 FR 22439.

External website: https://www.federalregister.gov/documents/2021/04/...

The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder provides eligible US physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives, who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services (i.e., psychosocial services).


Item Type
Report
Publication Type
International, Guideline, Report
Drug Type
Opioid
Intervention Type
Drug therapy
Date
28 April 2021
Identification #
86 FR 22439
Pages
2 p.
Publisher
Department of Health and Human Services
Corporate Creators
Office of the Secretary, Department of Health and Human Services
Place of Publication
Washington DC
EndNote

Repository Staff Only: item control page